CAMBRIDGE NUCLEOMICS LTD
Research and experimental development on biotechnology
CAMBRIDGE NUCLEOMICS LTD
Research and experimental development on biotechnology
Contact & Details
Contact
Registered Address
Meditrina Building Babraham Research Campus Cambridge CB22 3AT England
Full company profile for CAMBRIDGE NUCLEOMICS LTD (13135667), an active company based in Cambridge, England. Incorporated 15 Jan 2021. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2022–2024)
Cash in Bank
£10.39k
Net Assets
-£107.31k
Total Liabilities
£142.85k
Turnover
N/A
Employees
2
Debt Ratio
402%
Financial History
Revenue, profit, EBITDA and key financial figures
2024 Dec Year End | 2023 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
No fundraising or grants recorded
Investors (0)
No investor information available
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Hendrik Friedrich Peter Runge | Director | German | England | 17 Oct 2022 | Active |
| John Mark Yeomans | Director | British | England | 3 Mar 2025 | Active |
| Max Zhu | Director | Chinese | Hong Kong | 6 Mar 2025 | Active |
See all 6 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (2)
Mr Hendrik Friedrich Peter Runge
German
- Ownership Of Shares 25 To 50 Percent
- Voting Rights 25 To 50 Percent
Ulrich Felix Keyser
German
- Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent
Max Zhu
Ceased 1 Aug 2022
Group Structure
Group Structure
No group structure identified
Charges
Charges
No charges registered
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 23 Mar 2026 | Accounts | Annual accounts made up to 2025-06-30 | |
| 28 Jan 2026 | Confirmation Statement | Confirmation statement made on 2026-01-14 with updates | |
| 28 Jan 2026 | Persons With Significant Control | Cessation of Ulrich Felix Keyser as a person with significant control on 2025-03-03 | |
| 28 Jan 2026 | Officers | Appointment of Dr Anthony Cooke as director on 2026-01-26 | |
| 28 Jan 2026 | Persons With Significant Control | Change to Mr Hendrik Friedrich Peter Runge as a person with significant control on 2025-03-03 |
Annual accounts made up to 2025-06-30
Confirmation statement made on 2026-01-14 with updates
Cessation of Ulrich Felix Keyser as a person with significant control on 2025-03-03
Appointment of Dr Anthony Cooke as director on 2026-01-26
Change to Mr Hendrik Friedrich Peter Runge as a person with significant control on 2025-03-03
Recent Activity
Latest Activity
Annual accounts made up to 2025-06-30
4 weeks ago on 23 Mar 2026
Confirmation statement made on 2026-01-14 with updates
2 months ago on 28 Jan 2026
Cessation of Ulrich Felix Keyser as a person with significant control on 2025-03-03
2 months ago on 28 Jan 2026
Appointment of Dr Anthony Cooke as director on 2026-01-26
2 months ago on 28 Jan 2026
Change to Mr Hendrik Friedrich Peter Runge as a person with significant control on 2025-03-03
2 months ago on 28 Jan 2026